Atlas Trials

AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce

Clinical trial NCT05216172 · COMPLETED

Trial details

NCT number
NCT05216172
Sponsor
Queen Mary University of London
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 DiabetesDiabetes Mellitus, Type 2Renal TransplantKidney Transplant; ComplicationsEnd Stage Renal Disease
Start date
2019-12-13
Primary completion
2022-09-11
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.